Virginia Retirement Systems Et Al Arrowhead Pharmaceuticals, Inc. Transaction History

Virginia Retirement Systems Et Al

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 May 16, 2023	BUY	$29.63 - $48.31 $103,705 - $169,085	3,500 Added 71.43%	8,400 $278 Million
Q4 2021 Feb 03, 2022	SELL	$58.09 - $82.51 $87,135 - $123,765	-1,500 Reduced 23.44%	4,900 $325,000
Q3 2021 Oct 21, 2021	SELL	$58.38 - $84.96 $210,168 - $305,856	-3,600 Reduced 36.0%	6,400 $400,000
Q2 2021 Aug 13, 2021	SELL	$62.15 - $90.32 $12,430 - $18,064	-200 Reduced 1.96%	10,000 $828,000
Q1 2021 Apr 30, 2021	SELL	$61.35 - $90.47 $24,540 - $36,188	-400 Reduced 3.77%	10,200 $676,000
Q4 2020 Feb 16, 2021	SELL	$43.82 - $85.37 $131,460 - $256,110	-3,000 Reduced 22.06%	10,600 $813,000
Q3 2020 Nov 12, 2020	SELL	$33.21 - $51.27 $172,692 - $266,604	-5,200 Reduced 27.66%	13,600 $586,000
Q2 2020 Aug 12, 2020	BUY	$26.12 - $43.27 $216,796 - $359,141	8,300 Added 79.05%	18,800 $812,000
Q1 2020 May 12, 2020	BUY	$20.56 - $63.12 $92,520 - $284,040	4,500 Added 75.0%	10,500 $302,000
Q4 2019 Jan 27, 2020	BUY	$28.14 - $73.01 $168,840 - $438,060	6,000 New	6,000 $381,000
Q3 2019 Oct 22, 2019	SELL	$26.26 - $34.86 $603,980 - $801,780	-23,000 Closed	0 $0
Q2 2019 Jul 26, 2019	BUY	$17.43 - $28.82 $29,631 - $48,994	1,700 Added 7.98%	23,000 $610,000
Q1 2019 Apr 25, 2019	BUY	$12.05 - $20.18 $256,665 - $429,834	21,300 New	21,300 $391,000
Q4 2018 Feb 07, 2019	SELL	$10.74 - $19.7 $234,132 - $429,460	-21,800 Closed	0 $0
Q3 2018 Nov 02, 2018	BUY	$14.0 - $20.3 $305,200 - $442,540	21,800 New	21,800 $418,000

295

91.1M

155K

426K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $1.96B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Virginia Retirement Systems Et Al, based on Form 13F filings with the SEC.

Stay updated on Virginia Retirement Systems Et Al with notifications on news.